Latest filing published 21 May 2020 for Traws Pharma, Inc., €3,318.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +21.6%Entry US$157.50 · Close at T+365 US$191.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jerome Groopman: trading record in brief
All filings by Jerome Groopman on record concern Traws Pharma, Inc. Over a trading history stretching from 29 June 2016 to 19 May 2020, the count stands at 2 filings.
On the market, this insider has only ever bought: 1 purchase, €3,318 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise. So far in 2020, the count stands at 1 purchase and no sales.
The newest entry dates from 21 May 2020: an open-market purchase of €3,318, in Traws Pharma, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jerome Groopman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.3626100.0% of flowCommon StockSEC:0001179110-20-006452:0Canonical exit: 17 Aug 2020 (T+90)
- 10 shares@ US$5.201.4% of flowCommon StockSEC:0001179110-16-028546:0
2 of 2 declarations